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Abstract 
Introduction: 
     Chronic sterile inflammation that underlies obesity can promote unhealthy cellular changes 
eventually leading to a decline in metabolic health and type-2 diabetes. Dysregulation of 
cellular processes during the initiation and progression of obesity can impair inflammatory 
homeostasis leading to a proinflammatory Th17 cytokine profile by CD4+Tcells. Our 
ongoing research efforts are to understand the mechanistic link between the changes in a 
cellular housekeeping process known as autophagy and the regulation of Th17 cytokines in 
obese non diabetic and diabetic subjects.  
    
Methods:  
 
We assessed cellular protein expression and colocalization using immunoblotting, 
immunofluorescence, flow cytometry and ELISA assays. 
 
Results:  
   
  We observed that diabetic obese subjects had lower autophagy (p<0.05), mitochondrial 
fission (p<0.05) and lower expression of antioxidant proteins such as nicotinamide 
transhydrogenase and super oxide dismutase 2(numerical reduction). The diabetic subjects 
had numerically higher mitochondrial fusion protein expression, significantly higher 
mitochondrial mass and mitochondrial colocalization with lysosomal protein 
LAMP1(p<0.05). No difference was observed in cytokines IL17A and IL-17F between the 
groups as assessed via intracellular staining.  
 
Conclusion:  
   
  The preliminary data presented in this study shows that CD4+ T cells from obese diabetic 
subjects have significantly higher number of fused mitochondria along with lower 
mitochondrial antioxidant protein expression. While we observed that the cellular recycling 
process of autophagy is lower in the diabetic subjects the mitochondrial colocalization with 
lysosomal protein appears to be intact. Further experimental analysis is required to 
understand this discrepancy.  
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Introduction 
Metabolic diseases such as type 2 diabetes (T2D) and obesity are characterized by mitochondrial 
dysfunction, reactive oxygen generation, higher pro-inflammatory cytokine production and 
activation of numerous detrimental cellular signaling pathways. Perturbations in cellular 
metabolism and intracellular signaling can dysregulate inflammatory homeostasis.  Pro-
inflammatory cytokines, such as those produced by a subset of T cells known as Th17s, i.e IL-
17A, IL-17F, IL-21, are produced at higher concentrations in peripheral blood mononuclear cells 
(PBMCs) from subjects with type 2 diabetes (T2D)(Jagannathan-Bogdan et al., 2011) (Ip et al., 
2016). This Th17 signature has not been identified in mouse models of T2D or aging, suggesting 
that it is a distinctly human trait   Our work to identify mechanisms underlying the Th17 profile 
showed that a partial profile was produced by cells treated in vitro with the dietary fatty acid 
palmitate, a nutrient present at higher circulating concentrations in subjects that are 
obese(McCambridge et al., 2019) (Boden and Shulman, 2002; Boden, 2008). The partial 
recapitulation of the profile by palmitate could mimic the physiology somewhere along the 
continuum of progression from obesity to obesity-associated T2D, a speculation that would require 
substantial additional investigation.  
Dysfunctional mitochondria are often associated with cellular dysfunction in many cell types 
(Calabriso et al., 2018). Mitochondria are predominant contributors of cellular reactive oxygen 
species (ROS) which in turn regulates the many signaling pathways. The first report that 
mitochondria produce ROS came in 1966 and later Chance et al 1971 showed that isolated 
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mitochondria produce hydrogen peroxide. Normal physiological levels of ROS is necessary for 
cellular health as ROS serves as a signaling molecule. However exaggerated ROS has been 
associated with metabolic and age associated pathologies. Over exuberant, damaged and 
dysfunctional mitochondria that produce exaggerated   Excess ROS generating organelles are 
cleared from the cell by the cellular clean up and recycling process of autophagy(Strzyz, 2018). 
Damaged, dysfunctional and excess organelles are sequestered in a double membrane structure 
known as autophagosome. The autophagosome then fuses with the lysosome and the contents are 
degraded and recycled by lysosomal enzymes.  Dysregulation of autophagy would result in the 
accumulation of excess, damaged and dysfunctional mitochondria that generated more ROS. The 
cellular milieu becomes toxic if the antioxidant mechanism of the cell is unable to neutralize the 
ROS in concert with autophagy which removes the excess and dysfunctional ROS generating 
mitochondria. Exaggerated ROS is linked to aberrant effector function of T cells and  generation 
of proinflammatory cytokines especially the Th17 cytokines that are associated with diabetes 
(unpublished data)(Zhi et al., 2012).  Our objective was to access the expression of 
mitochondrial proteins, mitochondrial turn over (mitophagy) and antioxidant protein expression 
in α CD3/ α CD28 stimulated CD4+ T cells from non-diabetic obese subjects that are generally 
considered “metabolically healthy obese (MHO)” and diabetic obese subjects. 
 
Materials and Methods 
Human Subjects Sample Collection: 
Informed consent for all human samples was obtained following Institutional Review 
Board-approved protocols in accordance with the Declaration of Helsinki at University of 
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Kentucky, The Forsyth Institute, and Boston University.  Study design was cross-sectional. Obese 
non diabetic subjects (avg. 39.3 yrs,) and BMI-matched diabetic subjects (avg. 42 yrs) have 
additional characteristics shown in Table 1. Exclusion criteria were smoking, long-term or recent 
use of antibiotics or anti-inflammatory medications (i.e. NSAIDs; low-dose aspirin was not an 
exclusion), auto-immune disease and allergy medications, and pregnancy.   
 
Cellular Analyses:  
Fifty milliliters of peripheral blood were collected into acid/citrate/dextrose containing 
tubes by venous puncture. PBMCs were purified by histopaque 1077 followed by negative 
selection with CD4+ cell-excluding magnetic beads (Miltenyi, Auburn, CA) for experiments on 
purified T cells as we published 4. CD4+ T cells were >93% pure as assessed via flow cytometry.  
All cells were frozen at -80°C in a Mr. Frosty apparatus (Nalgene).  For multi-week storage, cells 
were moved to -170°C following 1-7 days at -80°C.  T cells from BMI-matched ND and T2D 
subjects were stimulated in vitro for 40 h with αCD3/αCD28 Dynabeads (Thermo Fisher Scientific, 
11132D) at 2μL/100k cells in RPMI media with 5mM glucose (euglycemic). The supernatant was 
stored at -80°C until analyzed in technical duplicate on a BioRad 3D instrument using a Th17 
multiplex kit (Miltenyi). Cells were assayed as outlined below.   
 
Autophagy and mitochondrial turnover: 
We quantified the formation of LC3 puncta after intracellular labelling using fluorescent 
antibodies to LC3 II protein (Mizushima et al., 2010).  Second, we measured mitochondrial 
turnover(Kubli and Gustafsson, 2012)  we visualized mitophagy through colocalization of TOM20 
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with LAMP1 using immunofluorescence as detailed below. Third, we visualized mitochondrial 
fission protein Dynamin related protein 1(Drp1) expression using confocal microscopy. Drp1 is 
known to regulate autophagy and promote mitochondrial removal by enhancing mitochondrial 
fission. 
Immunohistochemistry/Immunofluorescence: 
Activated CD4+ T cells from ND and T2D subjects were plated on coverslips coated with 
poly-D-lsine in 6-well plates. After 40 h, the cells were briefly centrifuged, washed 3 times with 
1X PBS and incubated in 4% paraformaldehyde for 30 min on ice. The coverslips were washed 
3X with PBS and 0.1% triton X-100 (PBST), and were blocked for 30 min in 5% BSA/PBST. 
Antibodies to TOM20 (Abcam, Cambridge, MA) and LAMP1 (Abcam, Cambridge, MA) were 
added at 1:50 dilution with incubation overnight at 4ºC. The coverslips were rinsed 3X with PBST 
and incubated with fluorophore-tagged secondary antibodies (TOM20 with anti-mouse Alexa 488 
and LAMP1 with anti- rabbit Alexa 680) (Rockland Immunochemicals, Limerick,PA) for 2h at 
RT. The coverslips were washed 3X with PBST and mounted on glass slides using Fluromount G 
(Southern Biotech, Birmingham, AL). Cell imaging under a 63X oil immersion lens was 
performed in a Zeiss confocal microscope. Three cells/field and 3 fields/slide were imaged on N=4 
slides and data were analyzed using Image J (Kirber et al., 2007; Vereb et al., 2000). 
Immunoblotting: 
Immunoblotting was used to quantify protein expression as we published [14,15]. The 
procedure was modified according to the cell type from which the proteins were extracted. Thirty 
μl of 1X cell lysis buffer (Cell Signaling Technology, Danvers, MA, US) was added to 1x106 cells 
and incubated on ice for 20 min. Cells were then centrifuged at 13,000 rpm for 20 min and 
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supernatant was collected. A Bicinchoninic Assay (Thermo Fisher Scientific, Waltham, MA, US) 
assessed protein concentration. Twenty μg protein was loaded in polyacrylamide gels and 
electrophoresis was performed at 100 V for 1 h. Transfer of protein to polyvinylidene difluoride 
(PVDF) membrane was performed at 45 V for 5 h. The membrane was blocked for 30 min at room 
temperature (RT) in blocking buffer containing 2% bovine serum albumin in TBST followed by 
overnight incubation at 4○C in the respective primary antibodies. The membrane was washed 3X 
with 1X TBST and incubated with secondary antibodies for 2h at RT, then imaged. Table 2 lists 
the antibodies used in this study. All antibodies were used at a dilution of 1:500 except α-actin 
which was used at 1:10,000. We quantified NNT, MnSOD and OPA1 expression on western blots 
using Image studio lite (Licor, Lincoln, NE, US) [16]. 
Statistical analyses: 
Data are presented as mean ± standard error of the mean (SEM). Unpaired 2-tailed t-tests 
compared means of two values. Significance was accepted when p< 0.05.  
 
Results and Discussion 
T cells from obese diabetic subjects had lower autophagy protein expression: 
CD4+ T cells were activated for 40 h with α CD3/α CD28 beads. The supernatant was 
collected after the completion of incubation for cytokine profiling. The cells were prepared for 
observing protein expression via confocal microscopy. Cells were probed with LC3 antibody that 
would bind the autophagosomes that are formed upon induction of autophagy and LC3 puncta 
would increase. Upon activation of CD4+ T cells autophagy induction is expected to occur in order 
to meet the increased biosynthetic needs of the cell as well as to neutralize the activation induced 
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ROS generation. We observed that CD4+ T cells from obese diabetic subjects had lower LC3 
puncta formation compared to CD4+ T cells from obese non diabetic subjects (Fig 1 panels A 
(images) and B(quantification)).  
 
T cells from obese subjects had lower Drp1 and higher OPA1 expression: 
The mitochondrial fission protein Drp1 and fusion protein OPA1 regulate the 
mitochondrial dynamics and function. It is know that mitochondria that are excessively fused are 
not effectively removed by mitophagy(Twig et al., 2008b). When the cell prepares for removal of 
damaged, dysfunctional or excess mitochondria, it upregulates the expression of Drp1 resulting in 
mitochondrial fission (Twig et al., 2008a). The cell also downregulates Opa1 thereby enhancing 
mitochondrial fission which will enable the mitochondria to be removed by autophagic 
machinery(Twig et al., 2008b). It is also reported that mitochondrial fission is necessary for 
effector function of T cells (Schumann et al., 2014). When mitochondrial fission occurs the 
mitochondrial move to regions of immunological synapses(IS) and position themselves in close 
proximity to the IS. This results in calcium influx into the cells and the influx is tightly regulated 
by mitochondria that are positioned close to the IS. Calcium influx into the cell promotes the 
effector cytokine production. Schumann et al, 2014 showed that in a mouse “knock in” model of 
TCAIM protein, TCAIM over expression resulted in reduction of Drp1 expression which 
prevented the movement of mitochondria to the IS causing a decrease in calcium influx and 
decreased effector cytokine production. We observed that the cells from T2D subjects had 
significantly lower levels of Drp1 expression (Fig 2 A (image) and B (quantification) and higher 
levels of OPA1 expression (Fig 2C). Our results show that mitochondrial fission is prevented 
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whereas the fusion of mitochondria is enhanced. Lower Drp1 expression along with lower 
autophagy indicates accumulation of fused mitochondria in T2D subjects.  
 
T2D increases T cell mitochondrial accumulation:  
Mitochondrial outer membrane protein translocase of outer membrane 20 (TOM20) 
expression was assessed via confocal microscopy. We observed that T cells from diabetic subjects 
had higher expression of TOM20 compared to the non-diabetic subjects indicating an increase in 
mitochondrial mass Fig 3 A and B. Next, we sought to determine if there is a change in the 
colocalization of TOM20 with the lysosome associated protein 1(LAMP1). An increased 
colocalization would indicate that mitochondria are in close proximity to the lysosome thereby 
implicating mitochondrial turnover. Surprisingly, our data showed that increased colocalization of 
mitochondrial protein TOM20 with LAMP1 occurred in T2D subjects when compared to the ND 
subjects Fig 4 A and B. Autophagy (LC3 puncta Fig 1A, B) being low but mitochondrial turn over 
being high is a discrepancy. Although not unusual this needs further investigation.  No difference 
in LAMP1 expression was observed Fig 3 C and D. 
 
T2D lowers antioxidant protein expression:  
Since T2D is associated with mitochondrial ROS we assessed the expression of important 
mitochondrial antioxidants protein such as nicotinamide nucleotide transhydrogenase (NNT) and 
manganese super oxide dismutase (MnSOD). NNT maintains the levels of NADPH and reduced 
glutathione (GSH) where as MnSOD detoxifies superoxide formed in the mitochondria. An 
impaired expression or function of these proteins would result in uncontrolled production of ROS 
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which will promote cellular dysfunction (McCambridge et al., 2019). We observed that the levels 
of both NNT (Fig 5A) and MnSOD (Fig 5B) were numerically lower in T2D cells compared to 
the cells from ND. This experiment was limited by the low N. 
 
Cytokine expression: 
We assessed cytokine expression either via intracellular staining and flow cytometry (Fig 
6 A and B) or by enzyme linked immunosorbent assay (ELISA- Fig 6 C). We did not observe a 
significant difference in IL17A or IL-17F production via flow analysis. However ELISA revealed 
that the non-diabetic obese subjects had higher levels of IL17A/F cytokine compared to the T2D 
subjects. The result was unexpected as we hypothesized that the T2D subjects would have higher 
production of the proinflammatory Th17 cytokine. Since the data set is derived from a limited 
number of subject’s further investigations with more subjects is required.  According to Schumann 
et al, lower Drp1 expression and autophagy may blunt effector function of T cells resulting in 
impaired cytokine production. This might be one conclusion. However, substantial investigation 
is required to further analyze our data and understand its physiological relevance in the context of 
obesity and diabetes. 
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Figure 1: T cells from diabetic subjects had less LC3 puncta formation. Lower punctuate structures(A) 
quantification (B) was observed in CD4+T cells from obese diabetic subjects compared to obese normoglycemic 
subjects A&B n=4, 3 cells/field and 3 fields/slide were imaged using 63X oil immersion in Zeiss microscope. each n 
represents T cells isolated from one subject. * p<0.05 vs. ND,  
 
 
 
Figure 2: T cells from diabetic subjects had lower Drp1 expression. Lower expression of DRP1 (A) quantification 
(B) was observed in CD4+T cells from obese diabetic subjects compared to obese normoglycemic subjects. Higher 
expression of mitochondrial fusion protein OPA1 was observed in T cells from diabetic subjects(C)  A&B n=4, 3 
cells/field and 3 fields/slide were imaged using 63X oil immersion in Zeiss microscope. C n= 2-3. each n represents 
T cells isolated from one subject. * p<0.05 vs. ND,  
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Figure 3: T cells from diabetic subjects had higher mitochondrial mass. Higher expression of TOM 20 (A) 
quantification (B) was observed in CD4+T cells from obese diabetic subjects compared to obese normoglycemic 
subjects indicating an increase in mitochondrial mass. No change in lysosomal protein LAMP1 was observed between 
the two groups (C and D). A-D n=3-4, 3 cells/field and 3 fields/slide were imaged using 63X oil immersion in Zeiss 
microscope. each n represents T cells isolated from one subject. * p<0.05 vs. ND,  
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Figure 4: T cells from diabetic subjects had more colocalization of mitochondria with the lysosome. Diabetic 
CD4+ T cells had more mitochondrial colocalization with lysosomal protein which may indicate a higher 
mitochondrial turnover. A (images), B(quantification). A and B n=2-3, 3 cells/field and 3 fields/slide were imaged 
using 63X oil immersion in Zeiss microscope. each n represents T cells isolated from one subject. * p<0.05 vs. ND,  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: T cells from diabetic subjects had lower expression of mitochondrial antioxidant proteins. Diabetic 
CD4+ T cells had numerically lower expression of mitochondrial antioxidant proteins NNT (A) and MnSOD (B). A 
and B n=2-3, each n represents T cells isolated from one subject. 
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Figure 6: Cytokine expression.  No change in Th17 cytokines IL-17A and IL-17F was observed between the groups 
after intracellular staining and flow cytometry analysis (A and B). However, ELISA assay (C) showed that non-
diabetic subjects had significantly higher levels of IL17A/F compared to the diabetic subjects. A and B n=6-8, C n=3. 
each n represents T cells isolated from one subject. * p<0.05 vs. ND, 
 
 
 
 
 
Table 1. Description of research subjects 
 
 
 
 
 
 
Table 2. Antibodies used in this study 
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All antibodies were used at a dilution of 1:500 except α-actin which was used at 1:10,000. 
 
 
 
 
 
 
 
 
Signaling events upon T cell activation a brief overview: 
 
CD4+ T cells are a type of lymphocyte that plays a major role in the body’s immune 
response by secretion of cytokines.  T cell activation that results from the presenting of cognate 
antigen by antigen presenting cells such as dendritic cells and macrophages is shown to create 
profound changes in cellular process such as metabolism and effector function. Activation causes 
CD4+ T cells to differentiate into different subtypes; Th1 cells, Th2 cells, Th17 cells, and 
regulatory T cells (Tregs). There are three main signaling pathways that happen with activation; 
PI3K-AkT, mTORC, and MAPK pathways. The activation of the kinases according to the signal 
received determines if the cells would differentiate into pro or anti-inflammatory effectors.  
It is known that T cells upon activation prefers aerobic glycolysis for ATP generation. During 
glycolysis glucose is converted to lactate instead of undergoing oxidative phosphorylation. 
Although the yield of ATP via glycolysis is significantly less than the ATP generated via 
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oxidative phosphorylation, cells prefer glycolysis upon activation for generation of redox balance 
regulators such as glutathione. The redox regulators are critical to neutralize activation induced 
ROS generation and for preserving cellular health.  CD4+ T cells produce cytokines, unlike naïve 
or memory cells. Naïve and memory cells are metabolically different from the effector cells and 
prefer mitochondrial oxidative phosphorylation while effector T cells prefer glycolysis due to the 
need for rapid biosynthesis and for antioxidant defenses.  
T cell activation requires engagement of the T-cell receptor (TCR) and costimulation 
through CD28 (Wahl et al., 2012). CD28 signaling activates the kinase Akt which results in 
translocation of GLUT1 transporter to the T cell membrane which is followed by glucose uptake 
and glycolysis. Akt-mTOR signaling can also promote glycolysis through various mechanisms 
such as phosphorylating GLUT1, modifying hexokinase; and transcriptionally regulating 
metabolism (Revu et al., 2018). CD28 costimulation, acting through phosphatidylinositol 3-
kinase (P13K) and Akt, is required to increase glycolytic rate in T cells (Clavijo and Frauwirth, 
2012). CD28 can amplify signals and activate kinase cascades like Akt and mTOR, which leads 
to activation and proliferation of the T cell. 
TCR signaling is known to promote activation of pyruvate dehydrogenase kinase 1 
(PDHK1) (Revu et al., 2018). This pathway activation inhibits mitochondrial import of pyruvate, 
facilitating the breakdown into lactate (Revu et al., 2018). Another major signaling pathway is 
mTOR, which interrupts the catabolic metabolism and mitochondrial oxidative phosphorylation 
as well as induces transcription of glycolytic enzymes to increase glycolysis. Akt activates 
mTOR signaling to promote protein synthesis of ATP citrate lyase to promote lipid synthesis 
(Ron-Harel et al., 2015). MTOR activation stimulates the activity of transcription factor Myc as 
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well as HIF-1α that enables the expression of enzymes of glycolytic pathways, thereby 
regulating the balance between pro and anti-inflammatory differentiation. Myc is associated with 
the upregulation of several glycolytic enzymes including GLUT1, hexokinase, 
phosphofructokinase, and lactate dehydrogenase (Wahl et al., 2012). Hexokinase is further 
induced by Erk after TCR activation.  
STAT5, Erk, and MAPKinases (MAPK) are other signaling pathways that may regulate cell 
metabolism depending on the condition. Activation of p38 MAPK requires dual phosphorylation 
at Thr180 and Tyr182 and can be mediated by two different pathways in T cells. Recruitment of 
linker for activation of T cells (LAT) and the activation of guanine nucleotide exchange factors 
(GEFs) is essential for activation of MAPK (Dodeller and Schulze-Koops, 2006). MAPK pathway 
results in regulation of cytokines expression such as TNF, IL-2, IL-4, IL-5 and IL-13. The 
activation of p38 MAPK is necessary for the expression of IL-10 and of the T helper type 2 (Th2) 
cytokines 1L-4, IL-6, and IL-10, but not for that of the Th1 cytokines IFN-y(Dodeller and Schulze-
Koops, 2006). CD4 T cells maintain their ability to proliferate and secrete cytokines at low levels 
of glucose (Wahl et al., 2012). (Seki and Gaultier, 2017) Glycolytic enzymes (Seki & Gaultier, 
2017). The glycolysis enzymes that play major roles in metabolic inflammation are Hexokinase II, 
Glyceraldehyde 3-phospahte dehydrogenase, α-Enolase, Pyruvate Kinase Isoform M2, and 
Lactate Dehydrogenase A. Hexokinase II (HK-II) catalyzes the phosphorylation of glucose to 
glucose 6-phosphate (G6P). HK-II appears to be closely linked to activation of inflammatory 
pathways in immune cells. AKT stabilizes the localization of HK-II to the outer mitochondrial 
membrane where HK-II has more access to mitochondria ATP. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) catalyzes conversion of glyceraldehyde 3-phosphate to 1, 3-
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bisphosphoglycerate. GAPDH is an energy sensor that regulates translation of inflammatory 
cytokine mRNA in response to the availability of glucose in the cell. α-Enolase catalyzes the 
conversion of 2-phosphoglycerate to phosphoenolpyruvate (PEP) in glycolysis. Pyruvate Kinase 
(PK) Isoform M2 is the ATP-generating enzyme that catalyzes the conversion of PEP to pyruvate 
during glycolysis. Lactate dehydrogenase is a tetrameric enzyme compose of A and B subunits 
that, when combined, form a complex with the capability of converting pyruvate to lactate, which 
is the defining step of glycolysis. This enzyme is also critical for the production of the 
inflammation-promotingcytokineIFN-γ. (Seki and Gaultier, 2017) 
 
Mitochondrial antioxidant proteins: 
NNT-  
Nicotinamide nucleotide transhydrogenase (NNT) is an integral protein of the inner 
mitochondrial membrane. This protein plays a role in the production of NADPH, which is 
involved in removing reactive oxygen species (ROS) that could damage the membrane and its 
function. NNT catalyzes the reduction of NADP+ by NADH and the conversion of NADH to 
NAD+. We saw that low levels of NNT also caused a reduction in antioxidant expression such as 
NADPH. We found circulatory free fatty acids resulted in decreased function and expression of 
NNT, a key redox regulator, which lead to a redox imbalance and higher ROS levels.  
 
MnSOD-  
Manganese superoxide dismutase (MnSOD) is the essential mitochondrial antioxidant 
enzyme that detoxifies superoxide, a free radical. Its dismutase function is fully activated in the 
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mitochondria to detoxify free radical O2 and is upregulated by oxidative stress (Candas & Li, 
2014). This enzyme constitutes an important control switch in the process of activation-induced 
oxidative signal generation in T cells(Kaminski et al., 2012). Kaminski et al showed the 
association between T cell receptor (TCR)-triggered ROS production and higher MnSOD 
abundance/activity and a shut-down phase of oxidative signal generation (Kaminski et al., 2012). 
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